be a potential market in the future. For Medical Devices; There is still intense competition in both domestic and foreign markets. Market leaders use price strategies to gain market share. But the
Consolidated Financial Statements ended 31 December 2017, which have been audited by the Company’s authorized auditor. The company would like to clarify the operating results of the Company and its subsidiary
Profit (Loss) (16.93) (2.20) 14.73 669.55 Earnings per share (Baht per share) (0.0032) (0.0005) 0.0027 540.00 Net Profit (Loss) The Company and subsidiaries (Consolidated) realized net loss of 16.93
“Company”) submitted its separate financial statement and its consolidated financial statement for the second quarter of 2019 ended on 30 June 2019 which were reviewed by the auditor. The Company hereby
“Company”) submitted its separate financial statement and its consolidated financial statement for the second quarter of 2018 and 6 months ended on 30 June 2018 which were reviewed by the auditor. The
Revenues 27,838 23,204 791 672 28,629 23,876 4,753 20% Total Expenses (26,000) (21,695) (705) (606) (26,705) (22,301) 4,404 20% Share of Profit (Loss) 5,022 6,231 67 56 5,089 6,287 (1,198) (19%) Gain on
license, and lease liability paid). In summary, net cash increased by Bt8,520mn resulting in an outstanding cash of Bt23,263mn at the end of Mar-24. Net FX gain (loss) in 1Q24 was a loss of Bt-198mn amid
ะหข์องฝ่ายจัดการ | 2 หมายเหตุ : (1) Adjusted EBITDA คือ EBITDA ที(ไม่รวมผลกระทบจาก Stock Gain/(Loss) และ ค่าเผื(อมูลค่าของสนิคา้คงเหลือ (NRV) บทสรปุผูบ้รหิาร ในปี 2560 ภาพรวมของผลผลิตปาล์มนํ5ามันทั 5งใน
’ meeting date. 8. Acquisition and disposition of assets Transaction value : The total value of consideration is equal to 12.81% of the company’s total assets (calculation from the company’s consolidated